XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Fair Value of The Incentive Shares Estimated Using An Option Pricing Model

The fair value of the incentive shares was estimated using an option pricing model with the following assumptions:

 

 

 

Nine Months Ended
September 30,

 

 

2021

Common share fair value

 

$6.36 - $8.89

Participating threshold

 

$6.36 - $7.51

Risk free rate

 

0.14%

Volatility

 

72.90%

Time to liquidity (in years)

 

0.20 - 1.80

Grant date fair value

 

$4.24 - $4.52

Summary of The Unvested Common Stock The following table provides a summary of the unvested common stock awards activity during the nine months ended September 30, 2022.

 

 

 

Number of
Shares

 

 

Weighted Average
Grant Date Fair Value
Per Share

 

Unvested common stock as of December 31, 2021

 

 

3,753,862

 

 

$

16.00

 

Vested

 

 

(1,341,702

)

 

$

16.00

 

Forfeiture

 

 

(171,458

)

 

$

16.00

 

Unvested common stock as of September 30, 2022

 

 

2,240,702

 

 

$

16.00

 

Summary of Stock Option Activity Under The 2021 Plan

The following table provides a summary of stock option activity under the 2021 Plan during the nine months ended September 30, 2022.

 

 

 

Options

 

 

Weighted-Average
Exercise Price
Per Share

 

 

Weighted-Average
Remaining
Contractual Term

 

 

Aggregate
Intrinsic Value
(in thousands)

 

Outstanding at December 31, 2021

 

 

5,071,896

 

 

$

16.90

 

 

 

 

 

 

 

Granted

 

 

2,868,380

 

 

$

14.81

 

 

 

 

 

 

 

Exercised

 

 

(130,899

)

 

$

15.95

 

 

 

 

 

 

 

Forfeiture

 

 

(361,569

)

 

$

15.09

 

 

 

 

 

 

 

Outstanding at September 30, 2022

 

 

7,447,808

 

 

$

16.20

 

 

 

8.8

 

 

$

31,456

 

Exercisable at September 30, 2022

 

 

1,927,895

 

 

$

16.35

 

 

 

8.3

 

 

$

7,637

 

 

Summary of Restricted Stock Units Activity Under the 2021 Plan

The following table provides a summary of restricted stock units activity under the 2021 Plan during the nine months ended September 30, 2022:


 

 

 

Number of
Shares

 

 

Weighted Average
Grant Date Fair Value
Per Share

 

Unvested restricted stock units at December 31, 2021

 

 

96,890

 

 

$

22.93

 

Granted

 

 

417,995

 

 

$

14.57

 

Vested

 

 

(51,030

)

 

$

15.23

 

Forfeiture

 

 

(28,285

)

 

$

14.11

 

Unvested restricted stock units at September 30, 2022

 

 

435,570

 

 

$

16.38

 

Schedule of fair value of our common stock to be issued under the ESPP The fair value of our common stock to be issued under the ESPP is estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2022

 

2021

 

 

2022

 

2021

 

Expected term (in years)

 

0.50

 

 

 

 

0.50

 

 

 

Expected volatility

 

58.49%

 

 

 

 

58.49%

 

 

 

Risk-free interest rate

 

1.54%

 

 

 

 

1.54%

 

 

 

Expected dividend yield

 

 

 

 

 

 

 

 

Summary of The Black-Scholes Option Pricing Model to Estimate The Fair Value of Performance Stock Option Granted

The Company used the Black-Scholes option pricing model to estimate the fair value of the PSO awards granted with the following assumptions:

 

 

 

Nine Months Ended
September 30,

 

 

 

2022

 

2021

 

Expected term (in years)

 

2.92 - 3.42

 

 

 

Expected volatility

 

72.72% - 72.98%

 

 

 

Risk-free interest rate

 

3.37%

 

 

 

Expected dividend yield

 

 

 

 

Summary of Share/Stock-based Compensation Expense Recorded in The Accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss

Share/stock-based compensation expense recorded in the accompanying condensed consolidated statements of operations is as follows (in thousands):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Research and development expense

 

$

2,020

 

 

$

1,489

 

 

$

6,242

 

 

$

2,321

 

General and administrative expense

 

 

6,556

 

 

 

3,660

 

 

 

14,167

 

 

 

5,903

 

Total share-based compensation expense

 

$

8,576

 

 

$

5,149

 

 

$

20,409

 

 

$

8,224